Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease: Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

Standard

Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease : Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry. / Glintborg, B.; Kringelbach, T. M.; Høgdall, E.; Sørensen, I. J.; Jensen, D. V.; Loft, A. G.; Hendricks, O.; Jensen Hansen, I. M.; Bolstad, N.; Grøn, K.; Eng, G.; Enevold, C.; Nielsen, C. H.; Warren, D.; Goll, G.; Gehin, J.; Johansen, J. S.; Hetland, M. L.

I: Annals of the Rheumatic Diseases, Bind 75, Nr. Suppl 2, THU0123 , 2016.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

Harvard

Glintborg, B, Kringelbach, TM, Høgdall, E, Sørensen, IJ, Jensen, DV, Loft, AG, Hendricks, O, Jensen Hansen, IM, Bolstad, N, Grøn, K, Eng, G, Enevold, C, Nielsen, CH, Warren, D, Goll, G, Gehin, J, Johansen, JS & Hetland, ML 2016, 'Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease: Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry', Annals of the Rheumatic Diseases, bind 75, nr. Suppl 2, THU0123 . https://doi.org/10.1136/annrheumdis-2016-eular.1477

APA

Glintborg, B., Kringelbach, T. M., Høgdall, E., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Jensen Hansen, I. M., Bolstad, N., Grøn, K., Eng, G., Enevold, C., Nielsen, C. H., Warren, D., Goll, G., Gehin, J., Johansen, J. S., & Hetland, M. L. (2016). Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease: Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry. Annals of the Rheumatic Diseases, 75(Suppl 2), [THU0123 ]. https://doi.org/10.1136/annrheumdis-2016-eular.1477

Vancouver

Glintborg B, Kringelbach TM, Høgdall E, Sørensen IJ, Jensen DV, Loft AG o.a. Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease: Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry. Annals of the Rheumatic Diseases. 2016;75(Suppl 2). THU0123 . https://doi.org/10.1136/annrheumdis-2016-eular.1477

Author

Glintborg, B. ; Kringelbach, T. M. ; Høgdall, E. ; Sørensen, I. J. ; Jensen, D. V. ; Loft, A. G. ; Hendricks, O. ; Jensen Hansen, I. M. ; Bolstad, N. ; Grøn, K. ; Eng, G. ; Enevold, C. ; Nielsen, C. H. ; Warren, D. ; Goll, G. ; Gehin, J. ; Johansen, J. S. ; Hetland, M. L. / Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease : Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry. I: Annals of the Rheumatic Diseases. 2016 ; Bind 75, Nr. Suppl 2.

Bibtex

@article{edff73d67eba41bca8a80ad7c32cdfb0,
title = "Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease: Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry",
author = "B. Glintborg and Kringelbach, {T. M.} and E. H{\o}gdall and S{\o}rensen, {I. J.} and Jensen, {D. V.} and Loft, {A. G.} and O. Hendricks and {Jensen Hansen}, {I. M.} and N. Bolstad and K. Gr{\o}n and G. Eng and C. Enevold and Nielsen, {C. H.} and D. Warren and G. Goll and J. Gehin and Johansen, {J. S.} and Hetland, {M. L.}",
year = "2016",
doi = "10.1136/annrheumdis-2016-eular.1477",
language = "English",
volume = "75",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "Suppl 2",

}

RIS

TY - ABST

T1 - Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease

T2 - Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry

AU - Glintborg, B.

AU - Kringelbach, T. M.

AU - Høgdall, E.

AU - Sørensen, I. J.

AU - Jensen, D. V.

AU - Loft, A. G.

AU - Hendricks, O.

AU - Jensen Hansen, I. M.

AU - Bolstad, N.

AU - Grøn, K.

AU - Eng, G.

AU - Enevold, C.

AU - Nielsen, C. H.

AU - Warren, D.

AU - Goll, G.

AU - Gehin, J.

AU - Johansen, J. S.

AU - Hetland, M. L.

PY - 2016

Y1 - 2016

U2 - 10.1136/annrheumdis-2016-eular.1477

DO - 10.1136/annrheumdis-2016-eular.1477

M3 - Conference abstract in journal

VL - 75

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl 2

M1 - THU0123 

ER -

ID: 180616629